Details for New Drug Application (NDA): 078979
✉ Email this page to a colleague
The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 078979
| Tradename: | DIVALPROEX SODIUM |
| Applicant: | Dr Reddys Labs Ltd |
| Ingredient: | divalproex sodium |
| Patents: | 0 |
Pharmacology for NDA: 078979
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 078979
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIVALPROEX SODIUM | divalproex sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 078979 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8237 | 0615-8237-05 | 15 CAPSULE in 1 BLISTER PACK (0615-8237-05) |
| DIVALPROEX SODIUM | divalproex sodium | CAPSULE, DELAYED REL PELLETS;ORAL | 078979 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8237 | 0615-8237-28 | 28 CAPSULE in 1 BLISTER PACK (0615-8237-28) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 125MG VALPROIC ACID | ||||
| Approval Date: | Jan 23, 2009 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
